chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia, Tremor
Clinical narrative: moderate to severe headache; Weakness; Lightheadedness; shaking uncontrollably without any chills; Nausea; Shoulder pain; 102.1 fever; Back spasms; Neck pain; Unable to eat; Unable to sleep; stomach pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TREMOR (shaking uncontrollably without any chills), MUSCLE SPASMS (Back spasms), NECK PAIN (Neck pain), FEEDING DISORDER (Unable to eat) and INSOMNIA (Unable to sleep) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 036AZLA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heller's esophagomyotomy (hellermyotomy). Concurrent medical conditions included Asthma and Celiac disease.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced MUSCLE SPASMS (Back spasms), NECK PAIN (Neck pain), FEEDING DISORDER (Unable to eat), INSOMNIA (Unable to sleep), ABDOMINAL PAIN UPPER (stomach pain), ARTHRALGIA (Shoulder pain) and PYREXIA (102.1 fever). On 18-Mar-2021 at 7:00 PM, the patient experienced NAUSEA (Nausea). On 18-Mar-2021 at 9:00 PM, the patient experienced TREMOR (shaking uncontrollably without any chills). On 19-Mar-2021, the patient experienced ASTHENIA (Weakness) and DIZZINESS (Lightheadedness). On 20-Mar-2021, the patient experienced HEADACHE (moderate to severe headache). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 4 milligram. At the time of the report, TREMOR (shaking uncontrollably without any chills), MUSCLE SPASMS (Back spasms), NECK PAIN (Neck pain), FEEDING DISORDER (Unable to eat), INSOMNIA (Unable to sleep), ABDOMINAL PAIN UPPER (stomach pain), ASTHENIA (Weakness), DIZZINESS (Lightheadedness), NAUSEA (Nausea), ARTHRALGIA (Shoulder pain), PYREXIA (102.1 fever) and HEADACHE (moderate to severe headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 102.1 (High) Fever.         No concomitant medications provided.   This case was linked to MOD-2021-051475 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Additional information received included no new significant information
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Vaccination site erythema
Clinical narrative: she still has heat in her arm; there is a big red circle around the site; sore arm\progressively worsened; red arm which progressively worsened; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm\progressively worsened), ERYTHEMA (red arm which progressively worsened), FEELING HOT (she still has heat in her arm) and VACCINATION SITE ERYTHEMA (there is a big red circle around the site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm\progressively worsened) and ERYTHEMA (red arm which progressively worsened). On 19-Mar-2021, the patient experienced FEELING HOT (she still has heat in her arm) and VACCINATION SITE ERYTHEMA (there is a big red circle around the site). At the time of the report, PAIN IN EXTREMITY (sore arm\progressively worsened), ERYTHEMA (red arm which progressively worsened), FEELING HOT (she still has heat in her arm) and VACCINATION SITE ERYTHEMA (there is a big red circle around the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Weakness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced ASTHENIA (Weakness). On 03-Mar-2021, ASTHENIA (Weakness) had resolved. Not Provided          No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site nodule
Clinical narrative: knot in arm near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (knot in arm near injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NODULE (knot in arm near injection site). At the time of the report, VACCINATION SITE NODULE (knot in arm near injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  It was reported that patient did not have an adverse reaction. She just had a bump.    Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Clinical course of information updated.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Piloerection, Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (imbalance, described as just a little bit of dizziness), PILOERECTION (goosebumps), RHINORRHOEA (sinus drainage) and CHILLS (chills) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (patient has thirty year history of allergy to maple with sinus drainage). Concomitant products included METOPROLOL SUCCINATE, AMLODIPINE, FUROSEMIDE, GABAPENTIN, CALCIUM, IRON, BIOTIN, OMEPRAZOLE, ASPIRIN [ACETYLSALICYLIC ACID], LORATADINE, ASCORBIC ACID, COPPER GLUCONATE, FISH OIL, TOCOPHEROL, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (OCUVITE ADULT 50+ [ASCORBIC ACID;COPPER GLUCONATE;FISH OIL;TOCOPHEROL;XANTOFYL;ZEAXANTHIN;ZINC OXIDE]), VITAMIN 15, SUPER B COMPLEX WITH C, POTASSIUM and DULOXETINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced DIZZINESS (imbalance, described as just a little bit of dizziness). On an unknown date, the patient experienced PILOERECTION (goosebumps), RHINORRHOEA (sinus drainage) and CHILLS (chills). The patient was treated with PARACETAMOL at an unspecified dose and frequency. On 26-Feb-2021, DIZZINESS (imbalance, described as just a little bit of dizziness) had resolved. At the time of the report, PILOERECTION (goosebumps), RHINORRHOEA (sinus drainage) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: Sore Arm; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm), HEADACHE (Headache) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm), HEADACHE (Headache) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Sore Arm), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is taking concomitant medication , But not provided by Reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Abnormal behaviour, Anxiety, Fatigue, Hypertension
Clinical narrative: blood pressure started going bunkers - blood pressure was 164 over something, 148 over; totally raved up; anxious; heart palpitation; fatigue; body ache; nausea; sick to my stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (sick to my stomach), HYPERTENSION (blood pressure started going bunkers - blood pressure was 164 over something, 148 over), ABNORMAL BEHAVIOUR (totally raved up), ANXIETY (anxious) and PALPITATIONS (heart palpitation) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (sick to my stomach), FATIGUE (fatigue), MYALGIA (body ache) and NAUSEA (nausea). On an unknown date, the patient experienced HYPERTENSION (blood pressure started going bunkers - blood pressure was 164 over something, 148 over), ABNORMAL BEHAVIOUR (totally raved up), ANXIETY (anxious) and PALPITATIONS (heart palpitation). At the time of the report, ABDOMINAL PAIN UPPER (sick to my stomach), HYPERTENSION (blood pressure started going bunkers - blood pressure was 164 over something, 148 over), ABNORMAL BEHAVIOUR (totally raved up), ANXIETY (anxious), PALPITATIONS (heart palpitation), FATIGUE (fatigue), MYALGIA (body ache) and NAUSEA (nausea) outcome was unknown.            No concomitant and treatment drugs were reported.   This case was linked to MOD-2021-051480 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Palpitations
Clinical narrative: blood pressure started going bunkers - blood pressure was 164 over something, 148 over; totally raved up; anxious; heart palpitation; fatigue; body ache; nausea; sick to my stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (sick to my stomach), HYPERTENSION (blood pressure started going bunkers - blood pressure was 164 over something, 148 over), ABNORMAL BEHAVIOUR (totally raved up), ANXIETY (anxious) and PALPITATIONS (heart palpitation) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (sick to my stomach), FATIGUE (fatigue), MYALGIA (body ache) and NAUSEA (nausea). On an unknown date, the patient experienced HYPERTENSION (blood pressure started going bunkers - blood pressure was 164 over something, 148 over), ABNORMAL BEHAVIOUR (totally raved up), ANXIETY (anxious) and PALPITATIONS (heart palpitation). At the time of the report, ABDOMINAL PAIN UPPER (sick to my stomach), HYPERTENSION (blood pressure started going bunkers - blood pressure was 164 over something, 148 over), ABNORMAL BEHAVIOUR (totally raved up), ANXIETY (anxious), PALPITATIONS (heart palpitation), FATIGUE (fatigue), MYALGIA (body ache) and NAUSEA (nausea) outcome was unknown.            No concomitant and treatment drugs were reported.   This case was linked to MOD-2021-051480 (Patient Link).
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Suspected COVID-19
Clinical narrative: COVID SYMPTOMS; tested positive for covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid19) and SUSPECTED COVID-19 (COVID SYMPTOMS) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced COVID-19 (tested positive for covid19). On an unknown date, the patient experienced SUSPECTED COVID-19 (COVID SYMPTOMS). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for COVID-19, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for covid19) and SUSPECTED COVID-19 (COVID SYMPTOMS) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pyrexia, Vaccination site mass, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: Redness; A huge welt around the injection site; Feverish; Lump at the injection site which started itching; Lump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump at the injection site), VACCINATION SITE URTICARIA (A huge welt around the injection site), VACCINATION SITE PRURITUS (Lump at the injection site which started itching) and PYREXIA (Feverish) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B02A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and METOPROLOL for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE MASS (Lump at the injection site). On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Lump at the injection site which started itching). On 20-Mar-2021, the patient experienced VACCINATION SITE URTICARIA (A huge welt around the injection site) and PYREXIA (Feverish). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; Manual therapy (Ice) for Erythema and Manual therapy (Ice) for Vaccination site mass. At the time of the report, VACCINATION SITE MASS (Lump at the injection site), VACCINATION SITE PRURITUS (Lump at the injection site which started itching) and PYREXIA (Feverish) outcome was unknown and VACCINATION SITE URTICARIA (A huge welt around the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cough decreased, Ear swelling, Lymphadenopathy, Pain in extremity
Clinical narrative: Lymph nodes in mouth are swollen; Swelling from left ear down to upper part of arm and it was kind of hard to hear; Lymph nodes in neck swelled up horrible; Arm sore 1 hr later; 3 hours later lungs cleared and have not coughed since. I have been coughing for 5-7 years; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Mar-2021 and was forwarded to Moderna on 21-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore 1 hr later), EAR SWELLING (Swelling from left ear down to upper part of arm and it was kind of hard to hear), COUGH DECREASED (3 hours later lungs cleared and have not coughed since. I have been coughing for 5-7 years), LYMPHADENOPATHY (Lymph nodes in neck swelled up horrible) and LYMPHADENOPATHY (Lymph nodes in mouth are swollen) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm sore 1 hr later) and COUGH DECREASED (3 hours later lungs cleared and have not coughed since. I have been coughing for 5-7 years). On 17-Mar-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes in neck swelled up horrible). On 18-Mar-2021, the patient experienced EAR SWELLING (Swelling from left ear down to upper part of arm and it was kind of hard to hear). On 19-Mar-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes in mouth are swollen). At the time of the report, PAIN IN EXTREMITY (Arm sore 1 hr later), EAR SWELLING (Swelling from left ear down to upper part of arm and it was kind of hard to hear), COUGH DECREASED (3 hours later lungs cleared and have not coughed since. I have been coughing for 5-7 years), LYMPHADENOPATHY (Lymph nodes in neck swelled up horrible) and LYMPHADENOPATHY (Lymph nodes in mouth are swollen) outcome was unknown. Not Provided          Concomitant medication information not provided.  Treatment information not provided.  Action taken with mRNA-1273 in response to the event/s was not applicable.    This case was linked to MOD-2021-116896 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021: follow up was received on 09-May-2021: Consumer's HCP retired last year and 2 dose information provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Peripheral swelling
Clinical narrative: arm is swollen; pain in her muscles; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm is swollen) and MYALGIA (pain in her muscles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen) and MYALGIA (pain in her muscles). At the time of the report, PERIPHERAL SWELLING (arm is swollen) and MYALGIA (pain in her muscles) outcome was unknown.            After second dose vaccination the patient experienced pain in her muscles and swollen arm.No treatment information provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIARRHOEA (Diarrhoea). At the time of the report, DIARRHOEA (Diarrhoea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided   This case was linked to MOD-2021-051502, MOD-2021-051502 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness
Clinical narrative: Muscle weakness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle weakness) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Stroke.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (Muscle weakness). At the time of the report, MUSCULAR WEAKNESS (Muscle weakness) outcome was unknown.            No concomitant medications were reported. The patient's one side is already weak and is now on wheelchair. No treatment information was provided.   This case was linked to MOD-2021-059693 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow-up received on 11-05-2021: No newinformation
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever 102; Shakes from 2-4am; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 102) and CHILLS (Shakes from 2-4am) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included Pneumonia in December 2020. Concomitant products included LORAZEPAM for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PYREXIA (Fever 102) and CHILLS (Shakes from 2-4am). On 19-Mar-2021, CHILLS (Shakes from 2-4am) had resolved. At the time of the report, PYREXIA (Fever 102) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included use of Tylenol.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Breast mass, Pain in extremity, Vaccination site discolouration, Vaccination site mass
Clinical narrative: pain which spread to the back; injection site became purple; appeared a ball at the injection site and other ball between the breast and the arm; appeared a ball at the injection site and other ball between the breast and the arm; pain in both legs; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (pain which spread to the back), VACCINATION SITE DISCOLOURATION (injection site became purple), VACCINATION SITE MASS (appeared a ball at the injection site and other ball between the breast and the arm), BREAST MASS (appeared a ball at the injection site and other ball between the breast and the arm) and PAIN IN EXTREMITY (pain in both legs) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced BACK PAIN (pain which spread to the back), VACCINATION SITE DISCOLOURATION (injection site became purple), VACCINATION SITE MASS (appeared a ball at the injection site and other ball between the breast and the arm), BREAST MASS (appeared a ball at the injection site and other ball between the breast and the arm) and PAIN IN EXTREMITY (pain in both legs). At the time of the report, BACK PAIN (pain which spread to the back), VACCINATION SITE DISCOLOURATION (injection site became purple), VACCINATION SITE MASS (appeared a ball at the injection site and other ball between the breast and the arm), BREAST MASS (appeared a ball at the injection site and other ball between the breast and the arm) and PAIN IN EXTREMITY (pain in both legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment drugs were reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Additional info received- newevent added
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: rash looked like red dots; rash all over  stomache, back, and chest; rash all over stomache, back, and chest (itchy and dry); This spontaneous case was reported by a physician and describes the occurrence of RASH PRURITIC (rash all over stomache, back, and chest (itchy and dry)), RASH ERYTHEMATOUS (rash looked like red dots) and RASH (rash all over  stomache, back, and chest) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 013M20A) for COVID-19 immunization.     No medical history was provided by the reporter.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) from 05-Mar-2015 to an unknown date for Anxiety, ERGOCALCIFEROL, RETINOL (VITAMIN A + D), CALCIUM ASCORBATE (VITAMIN C [CALCIUM ASCORBATE]), ZINC, NITRIC OXIDE and FISH OIL (OMEGA 3 [FISH OIL]) for an unknown indication.   On 16-Feb-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 20-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH PRURITIC (rash all over stomache, back, and chest (itchy and dry)). On 20-Mar-2021 at 10:00 AM, the patient experienced RASH ERYTHEMATOUS (rash looked like red dots) and RASH (rash all over  stomache, back, and chest). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 27-Mar-2021, RASH PRURITIC (rash all over stomache, back, and chest (itchy and dry)), RASH ERYTHEMATOUS (rash looked like red dots) and RASH (rash all over  stomache, back, and chest) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered RASH PRURITIC (rash all over stomache, back, and chest (itchy and dry)), RASH ERYTHEMATOUS (rash looked like red dots) and RASH (rash all over  stomache, back, and chest) to be possibly related.    The action taken with mRNA-1273 in response to the event was not applicable.     Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Follow-up was received on 06-APR-2021. Reporter's address, ethnicity, race, height, weight were included. First dose vaccine start date, time, concomitant medications and event outcome were updated. Reporter's causality was updated to possible. It contains significant information.; Sender's Comments: This report refers to a case of Inappropriate schedule of product administration, for mRNA-1273, lot # unknown, with no associated AEs.  Based on the current available information and temporal association between the use of the product and the start date of the events, Rash pruritic and Rash Erythematous, a causal relationship cannot be excluded.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash that started in his forehead then spread to his neck, face, arms, legs, and back; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (rash that started in his forehead then spread to his neck, face, arms, legs, and back) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced RASH (rash that started in his forehead then spread to his neck, face, arms, legs, and back). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Rash all over, at a dose of 1 dosage form. At the time of the report, RASH (rash that started in his forehead then spread to his neck, face, arms, legs, and back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Surgical failure
Clinical narrative: Walking up and down steps was very painful; Lost effectiveness of ablation; Joint Pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GAIT DISTURBANCE (Walking up and down steps was very painful), SURGICAL FAILURE (Lost effectiveness of ablation) and ARTHRALGIA (Joint Pain) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 013620A) for COVID-19 vaccination.     The patient's past medical history included Back surgery (An ablation for back a month or so before the vaccination).   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced ARTHRALGIA (Joint Pain). On an unknown date, the patient experienced GAIT DISTURBANCE (Walking up and down steps was very painful) and SURGICAL FAILURE (Lost effectiveness of ablation). At the time of the report, GAIT DISTURBANCE (Walking up and down steps was very painful) and SURGICAL FAILURE (Lost effectiveness of ablation) outcome was unknown and ARTHRALGIA (Joint Pain) had resolved.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.    Most recent FOLLOW-UP information incorporated above includes: On 06-Jun-2021: Follow-up information received on 06-JUN-2021 contains significant information: Added relevant medical history, new events ("walking up and down steps was very painful", "lost effectiveness of ablation"). The outcome of the event (Joint pain) changed from not resolved to resolved. On 07-Jun-2021: Follow-up information received on 07-JUN-2021 contains non-significant information.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Headache, Illness, Myalgia
Clinical narrative: She felt very sick for 2 days; Taste like metal; Fever; Headache; Muscle pain; Chills; Nausea; Felt like vomiting for 2days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (She felt very sick for 2 days), DYSGEUSIA (Taste like metal), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (hospitalized in intensive care and received antibody therapy) on 20-Dec-2020. Concurrent medical conditions included Depression, Blood pressure management and Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ILLNESS (She felt very sick for 2 days), DYSGEUSIA (Taste like metal), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Felt like vomiting for 2days). At the time of the report, ILLNESS (She felt very sick for 2 days), DYSGEUSIA (Taste like metal), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Felt like vomiting for 2days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken were  Blood pressure meds Diabetes meds Depression meds The patient stated she seen a pulmonologist No treatment medications were reported
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: She felt very sick for 2 days; Taste like metal; Fever; Headache; Muscle pain; Chills; Nausea; Felt like vomiting for 2days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (She felt very sick for 2 days), DYSGEUSIA (Taste like metal), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Muscle pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (hospitalized in intensive care and received antibody therapy) on 20-Dec-2020. Concurrent medical conditions included Depression, Blood pressure management and Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ILLNESS (She felt very sick for 2 days), DYSGEUSIA (Taste like metal), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Felt like vomiting for 2days). At the time of the report, ILLNESS (She felt very sick for 2 days), DYSGEUSIA (Taste like metal), PYREXIA (Fever), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills), NAUSEA (Nausea) and VOMITING (Felt like vomiting for 2days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken were  Blood pressure meds Diabetes meds Depression meds The patient stated she seen a pulmonologist No treatment medications were reported
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for covid19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid19) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M26A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, MAGNESIUM, ATORVASTATIN CALCIUM (LIPITOR) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced COVID-19 (Tested positive for covid19). At the time of the report, COVID-19 (Tested positive for covid19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness
Clinical narrative: Could barely get her balance; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and BALANCE DISORDER (Could barely get her balance) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Rheumatoid arthritis, High cholesterol and ADD. Concomitant products included PRIMIDONE and PROPRANOLOL for an unknown indication.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizziness). On an unknown date, the patient experienced BALANCE DISORDER (Could barely get her balance). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness) and BALANCE DISORDER (Could barely get her balance) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient also takes ADD medications, statin low dose, Rheumatoid arthritis medications and high blood pressure medications.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Lethargy, Nausea
Clinical narrative: Dizziness; very lethargic; Fatigue; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), LETHARGY (very lethargic), FATIGUE (Fatigue) and NAUSEA (Nauseous) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Sulfa allergy). Concomitant products included METFORMIN HCL for Diabetes, LISINOPRIL for Hypertension, HYDROCHLOROTHIAZIDE and ANASTROZOLE for an unknown indication.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Nauseous). 18-Mar-2021, the patient experienced LETHARGY (very lethargic). The patient was treated with PARACETAMOL (TYLENOL) on 18-Mar-2021 for Fever, at a dose of q 6 hrs. On 20-Mar-2021, FATIGUE (Fatigue) had resolved. On 22-Mar-2021, DIZZINESS (Dizziness), LETHARGY (very lethargic) and NAUSEA (Nauseous) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive Abbot rapid antigen test. On 18-Mar-2021, Body temperature: 100.6 (High) High(in morning) and 102 (High) High  (in evening). On 19-Mar-2021, Body temperature: 100.2 (High) High(in morning) and 98.7 (High) High(in evening). On 20-Mar-2021, Body temperature: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) with lot no. 015m20a.   This case was linked to MOD-2021-056769, MOD-2021-259287 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Added Patient demographics, lab data, dose 1 information, treatment medication and event (fatigue). On 15-Jul-2021: Added Concomitant medications and updated reporter information, Patient demographics, Events stop date and outcome as recovered/resolved.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Dizziness; very lethargic; Fatigue; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), LETHARGY (very lethargic), FATIGUE (Fatigue) and NAUSEA (Nauseous) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Sulfa allergy). Concomitant products included METFORMIN HCL for Diabetes, LISINOPRIL for Hypertension, HYDROCHLOROTHIAZIDE and ANASTROZOLE for an unknown indication.    On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Fatigue) and NAUSEA (Nauseous). 18-Mar-2021, the patient experienced LETHARGY (very lethargic). The patient was treated with PARACETAMOL (TYLENOL) on 18-Mar-2021 for Fever, at a dose of q 6 hrs. On 20-Mar-2021, FATIGUE (Fatigue) had resolved. On 22-Mar-2021, DIZZINESS (Dizziness), LETHARGY (very lethargic) and NAUSEA (Nauseous) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive Abbot rapid antigen test. On 18-Mar-2021, Body temperature: 100.6 (High) High(in morning) and 102 (High) High  (in evening). On 19-Mar-2021, Body temperature: 100.2 (High) High(in morning) and 98.7 (High) High(in evening). On 20-Mar-2021, Body temperature: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) with lot no. 015m20a.   This case was linked to MOD-2021-056769, MOD-2021-259287 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Added Patient demographics, lab data, dose 1 information, treatment medication and event (fatigue). On 15-Jul-2021: Added Concomitant medications and updated reporter information, Patient demographics, Events stop date and outcome as recovered/resolved.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhoea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIARRHOEA (diarrhoea). At the time of the report, DIARRHOEA (diarrhoea) outcome was unknown. Not Provided          Patient experienced diarrhea after receiving both doses.   This case was linked to MOD-2021-051502 (E2B Linked Report).; Sender's Comments:  MOD-2021-051502:First dose
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 044A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, SIMVASTATIN, CALCIUM, FISH OIL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and CICLOSPORIN (RESTASIS) for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided          This case was linked to MOD-2021-051521 (Patient Link).
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Palpitations, Pharyngeal swelling
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (I have Shortness of breath/a hard time breath), PHARYNGEAL SWELLING (My throat was swelling, and the selling went down the same day) and PALPITATIONS (My heart was racing) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Heart disorder and Drug allergy (allergic to some antibiotics.).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (I have Shortness of breath/a hard time breath), PHARYNGEAL SWELLING (My throat was swelling, and the selling went down the same day) and PALPITATIONS (My heart was racing). At the time of the report, DYSPNOEA (I have Shortness of breath/a hard time breath), PHARYNGEAL SWELLING (My throat was swelling, and the selling went down the same day) and PALPITATIONS (My heart was racing) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: fast (High) heart was beating fast.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included for high blood pressure, heart and blood thinners. The patient reported that no treatment was given for events.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea, Vomiting
Clinical narrative: severe vomiting/non-stop vomiting all day; nausea; chills; body ache; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (severe vomiting/non-stop vomiting all day), NAUSEA (nausea), CHILLS (chills) and MYALGIA (body ache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high (she takes medicines for those) and Retinal artery occlusion (she takes medicines for those).    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VOMITING (severe vomiting/non-stop vomiting all day), NAUSEA (nausea), CHILLS (chills) and MYALGIA (body ache). At the time of the report, VOMITING (severe vomiting/non-stop vomiting all day), NAUSEA (nausea), CHILLS (chills) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported